Showing results (71-80 of 130) with videos related to
Sort By:
Pageof 13
Gynecologic Oncology|May 22, 2014
An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancerMonjri M Shah, Zachary C Dobbin, Somaira Nowsheen, et al.Oncogenesis|May 7, 2020
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1RSuresh Bugide, Keshab Raj Parajuli, Suresh Chava, et al.Biochemical and Biophysical Research Communications|July 18, 2019
Differential escape mechanisms in cetuximab-resistant head and neck cancer cellsChristopher D Willey, Joshua C Anderson, Hoa Q Trummell, et al.Critical Reviews in Oncology/Hematology|November 11, 2008
Evolution of clinical trials in head and neck cancerEddy S Yang, Barbara M Murphy, Christine H Chung, et al.Urology|December 3, 2014
Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyAndrew M McDonald, Christopher B Baker, Kiran Shekar, et al.Cancer Research|July 12, 2011
p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damageJuhong Jiang, Eddy S Yang, Guochun Jiang, et al.Cancers|August 7, 2021
Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast CancerYingnan Si, Ya Zhang, Hanh Giai Ngo, et al.Vaccines|August 28, 2021
Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast CancersYingnan Si, Ya Zhang, Jia-Shiung Guan, et al.Advances in Radiation Oncology|November 2, 2019
Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate CancerAndrew M McDonald, Samuel J Galgano, Jonathan E McConathy, et al.Ebiomedicine|May 26, 2019
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitorsAubrey L Miller, Samuel C Fehling, Patrick L Garcia, et al.Pageof 13